CGEM (CGEM) Stock Price & Analysis
CGEM (CGEM) fell 0.32% to USD 22.09 as of September 8, 2026 at 04:15 UTC, according to Nexqual real-time market data.
CGEM last closed at USD 22.09; the session ranged USD 21.84–22.29 on volume of 562,485 shares. Market capitalization is —, with a 52-week range of USD 5.68–23.19 (NMS). Source: Nexqual, September 8, 2026 at 04:15 UTC.
Key Statistics (as of September 8, 2026 at 04:15 UTC)
| Price | USD 22.09 |
|---|---|
| Change | ▼ 0.32% (down) |
| Previous Close | USD 22.09 |
| Open | USD 22.09 |
| Day Range | USD 21.84 – 22.29 |
| 52-Week Range | USD 5.68 – 23.19 |
| Volume | 562,485 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (CGEM)
Nexqual's technical model rates CGEM "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 04:15 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 60.42 (neutral) |
| vs SMA50 | Above (USD 19.12) |
| MACD | 1.05 (positive) |
From CGEM's Latest SEC 10-K Filing (filed 2026-03-10)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DSGN | Design Therapeutics, Inc. | USD 15.14 | ▼ 2.51% |
| IMCR | Immunocore Holdings plc | USD 36.13 | ▼ 3.32% |
| BCAB | BioAtla, Inc. | USD 1.74 | ▲ 43.98% |
| FHTX | Foghorn Therapeutics Inc. | USD 4.92 | ▼ 4.84% |
| EWTX | Edgewise Therapeutics, Inc. | USD 43.07 | ▲ 2.6% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:15 UTC. This page is informational and not investment advice.